These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6329868)

  • 1. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F; Mantelli L
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Propafenone in refractory supraventricular arrhythmias].
    Palumbo E; Svetoni N; Casini M; Spargi T; Biagi G; Lanzetta T
    G Ital Cardiol; 1984 May; 14(5):381-2. PubMed ID: 6468822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
    J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS; Rieder L
    Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
    G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D
    G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combinations of some anti-arrhythmia drugs].
    Di Marcotullio G; Milazzotto F; Dini P; Santini M; Ceci V; Polizzi C
    G Ital Cardiol; 1984 May; 14(5):360-6. PubMed ID: 6147292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA; Campos Peris JV; García García J; Jaen Armand E; Ruiz Ros JA; Salas Nieto J; Rodríguez Ruiz P; Marco Quiles J; Martínez Jérez M; Pico Aracil F
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 16. [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
    Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F; Botti G; Bonatti V; Rolli A
    G Ital Cardiol; 1983; 13(4):311-4. PubMed ID: 6884675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of propafenon in experimentally digitalis glycoside-induced arrhythmia].
    Germiniani H; Branco Germiniani CD; Iark FB; do Pillar MD
    Arq Bras Cardiol; 1979 Jul; 33(1):77-83. PubMed ID: 526179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA; Stiles GL; Shand DG
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.